In its fiscal year 2024 earnings review, Marico Limited painted a picture of robust health, achieving its highest-ever operating margins and laying out an ambitious roadmap for diversification. The company celebrated a 12% rise in operating profit to ₹2,026 crores on a top line of ₹9,653 crores, all while navigating a slow post-pandemic consumption recovery. The strategy was clear: leverage a strong core business to aggressively expand into Foods and Premium Personal Care, de-risk the international portfolio, and deliver consistent shareholder value.
But how does a strategy from 2024 look from the vantage point of late 2026? With the FMCG sector now facing margin pressures and broader market indices lagging, we’ll dissect Marico’s FY24 performance and guidance to assess whether its strategic bets were well-placed to navigate the current economic landscape. Was the margin peak of FY24 a summit or simply a new base camp for future growth? Let’s dive in.
To set the stage, let’s look at the headline numbers Marico reported for the financial year ending March 31, 2024. The performance was solid, marked by significant profitability gains even as a full-blown consumption revival remained elusive.
Metric | FY2024 Value | Year-over-Year Growth | Key Highlight |
---|---|---|---|
Consolidated Revenue | ₹9,653 crores | - | Stable performance in a tough environment. |
Operating Profit | ₹2,026 crores | +12% | Driven by strong margin expansion. |
Operating Margin | 21.0% | - | The company’s highest-ever recorded margin. |
Profit After Tax (Adj.) | ₹1,470 crores | +15% | Strong bottom-line growth. |
Dividend Per Share | ₹9.50 | - | Payout ratio of ~75% of recurring net profit. |
The key takeaway from FY24 was margin excellence. Management attributed this to robust gross margin expansion and confidently guided that operating margins would “structurally inch up over the next few years.” This optimism, however, now faces the headwind of sectoral margin pressure prevalent in 2026.
Marico operates a classic FMCG model but with a clear strategic pivot underway.
In FY24, Marico’s India business saw stable performance, with Modern Trade and E-commerce growing in double digits to account for ~30% of domestic sales. While the core held steady, the real story was the ambition laid out for the new growth engines.
Guidance from FY24:
Analysis from a 2026 Perspective:
This diversification strategy was Marico’s explicit answer to the low single-digit growth plaguing the broader FMCG space. From our current standpoint in August 2026, where the FMCG sector is an underperformer, the success of these two portfolios is paramount.
The key question for investors today is whether this strategic pivot created a truly resilient, high-growth consumer company or just a more complex version of a slow-growth stalwart.
Marico’s FY24 was defined by its record 21% operating margin. This was a stellar achievement, driven by a remarkable 800 bps gross margin expansion in the Foods business. The company guided for margins to continue their upward trajectory.
How does this look now?
The 2026 economic context points to FMCG margin pressure. This puts Marico’s optimistic FY24 guidance under the microscope.
Based on its FY24 performance, Marico was a Stalwart with “Fast Grower” ambitions. The subsequent two years have tested whether those ambitions could be realized profitably. A positive change would be seeing revenue growth accelerate while margins hold firm, even if slightly below the 21% peak.
In FY24, Marico’s international business grew 9% in constant currency and management made a key strategic point: they were actively reducing dependence on their largest international market, Bangladesh. They aimed to moderate Bangladesh’s revenue share to 40% by FY27, fueled by a ramp-up in MENA and South Africa.
Looking back from 2026, this was a particularly shrewd move. With global uncertainty, FPI outflows, and rising trade tensions (like the new 50% US tariffs), companies with diversified and de-risked global footprints are better positioned. By focusing on different growth corridors, Marico mitigated geopolitical and macroeconomic risks associated with any single emerging market. This strategy has likely provided a valuable cushion to its consolidated performance.
The shareholder Q&A in 2024 provided clues to the management’s thinking and market concerns:
Revisiting Marico’s FY24 results and strategy provides a powerful lesson in corporate foresight. The company identified the structural slowdown in its core and laid out a clear, albeit challenging, path to reignite growth through diversification into Foods and Premium Personal Care.
From today’s perspective, the investment thesis for Marico hinges on the execution of that 2024 plan.
Marico remains a Stalwart of the Indian consumer space, but its journey over the past two years has been about proving it can also be a Grower. In a stock-picker’s market, investors will need to see tangible proof that its new engines are not just running, but firing powerfully enough to drive the company forward against sectoral headwinds.